ODM-201, a New Generation Androgen Receptor Inhibitor for Castration-Resistant Prostate Cancer: Preclinical and Phase I Data.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.31.6_suppl.65

Related search